Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

301 Press Releases
DateTitleCompany
08 Jan 16 Takeda Provides Further Information about its New Business Venture with Teva Takeda ,
Published by
PharmiWeb.com
08 Jan 16 Takeda Announces Details of New Business Venture with Teva in Japan Takeda ,
Published by
PharmiWeb.com
08 Jan 16 Takeda to Present at the 34th Annual J.P. Morgan Healthcare Conference Takeda Pharmaceutical Company Limited,
Published by
Business Wire
06 Jan 16 Takeda Acquires U.S. Biologics Manufacturing Facility Takeda Pharmaceutical Company Limited,
Published by
Business Wire
28 Dec 15 CORRECTING and REPLACING Takeda Provides Further Information about Its New Business Venture with Teva Takeda Pharmaceutical Company Limited,
Published by
Business Wire
28 Dec 15 Takeda Provides Further Information about Its New Business Venture with Teva Takeda Pharmaceutical Company Limited,
Published by
Business Wire
18 Dec 15 Benefit/Risk Profile Remains Positive for Pioglitazone as an Important Treatment Option for Type 2 Diabetes Takeda Pharmaceutical,
Published by
PharmiWeb.com
18 Dec 15 Takeda Announces Sale of Respiratory Portfolio to AstraZeneca Takeda ,
Published by
PharmiWeb.com
18 Dec 15 Kyoto University's Center for iPS Cell Research Application and Takeda Launch the Joint Program for iPS Cell Applications Research at the Shonan Research Center (T-CiRA) Takeda,
Published by
PharmiWeb.com
18 Dec 15 Takeda's "Leuplin® PRO for Injection Kit 22.5 mg" Now Available for the Treatment of Prostate Cancer/Premenopausal Breast Cancer in Japan Takeda,
Published by
PharmiWeb.com
16 Dec 15 Takeda Announces Sale of Respiratory Portfolio to AstraZeneca Takeda Pharmaceutical Company Limited,
Published by
Business Wire
15 Dec 15 Kyoto University's Center for iPS Cell Research Application and Takeda Launch the Joint Program for iPS Cell Applications Research at the Shonan Research Center (T-CiRA) Takeda Pharmaceutical Company Limited,
Published by
Business Wire
11 Dec 15 NINLARO® (ixazomib) Now Available for Patients Takeda Pharmaceutical Company Limited,
Published by
Business Wire
10 Dec 15 Takeda and Cour Partner to Develop Novel Therapies for Celiac Disease and Other Gastrointestinal Diseases Takeda ,
Published by
PharmiWeb.com
08 Dec 15 Takeda and Cour Partner to Develop Novel Therapies for Celiac Disease and Other Gastrointestinal Diseases Takeda Pharmaceutical Company Limited,
Published by
Business Wire
06 Dec 15 Takeda Presents Data from Phase 3 TOURMALINE-MM1 Study for NINLARO® (ixazomib), First and Only Once-Weekly Oral Proteasome Inhibitor Recently Approved for Multiple Myeloma Takeda Pharmaceutical Company Limited,
Published by
Business Wire
02 Dec 15 Takeda Welcomes the Publication of New National Institute for Health and Care Excellence (NICE) Guidelines on the Management of Type 2 Diabetes in Adults Takeda UK Limited,
Published by
PR Newswire
30 Nov 15 "Copaxone® Subcutaneous Injection 20 mg Syringe" Now Available for the Treatment for Multiple Sclerosis in Japan Takeda Pharmaceutical ,
Published by
PharmiWeb.com
30 Nov 15 Teva and Takeda Establish Unique Partnership to Meet the Wide-Ranging Needs of Patients and Growing Importance of Generic Medicines Use in Japan Takeda Pharmaceutical Company Limited,
Published by
Business Wire
21 Nov 15 ADDING MULTIMEDIA U.S. FDA Approves Takeda’s NINLARO® (ixazomib), the First and Only Oral Proteasome Inhibitor to Treat Multiple Myeloma Takeda Pharmaceutical Company Limited,
Published by
Business Wire
13 Nov 15 Takeda UK strengthens its senior leadership team Takeda UK,
Published by
Liberation Unlimited
20 Nov 15 U.S. FDA Approves Takeda’s NINLARO® (ixazomib), the First and Only Oral Proteasome Inhibitor to Treat Multiple Myeloma Takeda Pharmaceutical Company Limited,
Published by
Business Wire
23 Nov 15 U.S. FDA Approves Takeda’s NINLARO® (ixazomib), the First and Only Oral Proteasome Inhibitor to Treat Multiple Myeloma Takeda,
Published by
PharmiWeb.com
06 Nov 15 Takeda to Present Data from Ixazomib’s Phase 3 Study in Relapsed/Refractory Multiple Myeloma at Upcoming American Society of Hematology Annual Meeting Takeda ,
Published by
PharmiWeb.com
01 Oct 15 New Drug Application Approval in Japan for Copaxone® Subcutaneous Injection 20 mg Syringe, a Drug for the Treatment of Multiple Sclerosis Takeda ,
Published by
PharmiWeb.com
01 Oct 15 Takeda selected for the sixth consecutive year for Dow Jones Sustainability Asia Pacific Index Takeda ,
Published by
PharmiWeb.com
02 Oct 15 Takeda Celebrates Fifth Annual Takeda Cares Day by Expanding Nationwide and Raising More Than $250,000 for Chicagoland Nonprofits Takeda Pharmaceuticals Company Limited,
Published by
PR Newswire
14 Oct 15 UCL and Takeda Announce a New Research Partnership to Identify Novel Therapeutic Targets for Neurodegenerative Diseases Takeda Pharmaceutical Company Limited,
Published by
Business Wire
20 Oct 15 Takeda Presents Vedolizumab Data at the 2015 American College of Gastroenterology (ACG) Annual Meeting Takeda ,
Published by
PharmiWeb.com
30 Oct 15 Takeda Reports Results for the First Half of FY2015 Confirms Management Guidance for the Full Year Takeda Pharmaceutical Company Limited,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.